New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
- 3 June 2020
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 109 (3) , 336-345
Abstract
A benzamidine derivative from diminazene was tested for a novel activity: treatment of primary open‐angle glaucoma. This drug was incorporated into mucoadhesive polymeric inserts prepared using chitosan (Chs) and chondroitin sulfate (CS). Of current interest is the mucoadhesion, which increases the contact time with the ocular surface, resulting in improved bioavailability; also, the inserts are made to act as a prolonged release system. In the present work the inserts were prepared by the solvent casting method using different polymeric proportions (30:70, 50:50, 75:25 % w/w Chs:CS and 100 % Chs). Thermal analysis and infrared spectroscopy both demonstrated physical dispersion of the active drug. The most promising was the 50:50 % Chs:CS which demonstrated that it was not fragile and has an in vitro release profile of up to 180 minutes. In addition, it presented greater adhesion strength in relation to the other formulations. These physicochemical results corroborate the in vivo tests performed. In this sense, we also demonstrated that the treatment with the 50:50 % insert can control the intraocular pressure (IOP) for at least three weeks and prevents damage to the retinal ganglion cells (RGCs) compared to the placebo insert. Thus, this indicates thus that the new drug is quite viable and promising in glaucoma treatment.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Pró-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (Scholarship)
This publication has 28 references indexed in Scilit:
- Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluationsInternational Journal of Pharmaceutical Investigation, 2012
- Rodent models of glaucomaBrain Research Bulletin, 2010
- Colon Delivery of Budesonide: Evaluation of Chitosan–Chondroitin Sulfate Interpolymer ComplexAAPS PharmSciTech, 2009
- In vitro release and characterization of chitosan films as dexamethasone carrierInternational Journal of Pharmaceutics, 2009
- Fabrication and characterization of chondroitin sulfate-modified chitosan membranes for biomedical applicationsDesalination, 2008
- Chitosan Formulations for Steroid Delivery: Effect of Formulation Variables on In Vitro CharacteristicsDrug Development and Industrial Pharmacy, 2007
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acidExperimental Eye Research, 2005
- Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administrationJournal of Controlled Release, 2005
- Ocular absorption following topical deliveryAdvanced Drug Delivery Reviews, 1995